MUSTANG BIO, INC. Notes Payable, Current
MUSTANG BIO, INC. (MBIO) had Notes Payable, Current of $5.00 million as of 2020-06-30, per its 10-Q filed 2020-08-10.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Debt, Current
us-gaap:NotesPayableCurrent · last filed 2020-08-10
- 2020-06-30: Notes Payable, Current $5.00M.
- 2020-03-31: Notes Payable, Current $3.13M.
- 2019-12-31: Notes Payable, Current $1.25M.
| Period end | Notes Payable, Current |
|---|---|
| 2020-06-30 | $5.00M 10-Q · filed 2020-08-10 |
| 2020-03-31 | $3.13M 10-Q · filed 2020-05-11 |
| 2019-12-31 | $1.25M 10-Q · filed 2020-08-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| BullFrog AI Holdings, Inc. (BFRG) | United States | $0.014B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Vyome Holdings, Inc (HIND) | United States | $0.014B | -1.38 |
| Tvardi Therapeutics, Inc. (TVRD) | United States | $0.014B |